Back
4D Molecular Therapeutics Stock Predictions
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
51
FDMT
4D Molecular Therapeutics
Last Price:
6.90
Seasonality Move:
19.19%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE4D Molecular Therapeutics Stock Forecast
- Over the next 52 weeks, 4D Molecular Therapeutics has on average historically fallen by 28.3% based on the past 3 years of stock performance.
- 4D Molecular Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is 4D Molecular Therapeutics Stock Undervalued?
The current 4D Molecular Therapeutics [FDMT] share price is $7.24. The Score for FDMT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal. - FDMT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will 4D Molecular Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, 4D Molecular Therapeutics has on average historically fallen by 28.3% based on the past 3 years of stock performance.
4D Molecular Therapeutics Stock Rating
Buy
51
4D Molecular Therapeutics (FDMT)
is a Buy
Is 4D Molecular Therapeutics overpriced?
- 4D Molecular Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
4D Molecular Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
4dmoleculartherapeutics.com
52-Week Data
52-Week High:
36.25
52-Week Low:
6.77
Prediction Charts
Market Cap:
334.69M
Price in USD:
7.24
Volume:
460.97K
Beta:
2.79
Technical Analysis
SMA50:
8.39
SMA100:
11.79
SMA200:
18.93
52-Wk Change:
-51.54%
Stock Predictions
-
Is 4D Molecular Therapeutics stock public?
Yes, 4D Molecular Therapeutics is a publicly traded company. -
What is the 4D Molecular Therapeutics stock quote today?
The 4D Molecular Therapeutics stock price is 7.24 USD today. -
How to buy 4D Molecular Therapeutics stock online?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-20 | 8.75 | 8.41 | 8.96 | 8.20 |
| Nov-21 | 8.41 | 7.99 | 8.48 | 7.83 |
| Nov-22 | 7.96 | 7.79 | 8.11 | 7.53 |
| Nov-25 | 7.89 | 7.62 | 8.23 | 7.52 |
| Nov-26 | 7.73 | 7.50 | 7.99 | 7.47 |
| Nov-27 | 7.51 | 7.87 | 7.89 | 7.44 |
| Nov-29 | 7.87 | 7.84 | 7.92 | 7.53 |
| Dec-2 | 7.80 | 7.59 | 7.94 | 7.50 |
| Dec-3 | 7.58 | 7.08 | 7.67 | 7.03 |
| Dec-4 | 7.05 | 7.14 | 7.25 | 6.95 |
| Dec-5 | 7.14 | 6.82 | 7.20 | 6.78 |
| Dec-6 | 6.86 | 7.35 | 7.44 | 6.77 |
| Dec-9 | 7.35 | 7.18 | 7.58 | 7.11 |
| Dec-10 | 7.20 | 7.24 | 7.33 | 6.99 |
4D Molecular Therapeutics Earnings
4D Molecular Therapeutics Earnings Report: Per Share 4D Molecular Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
4D Molecular Therapeutics Forecast Revenue Growth
4D Molecular Therapeutics Stock Analysis: Historical quarterly revenues per share for 4D Molecular Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.69 per share.
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.